Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Classical Hodgkin Lymphoma”

46 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 46 results

Early research (Phase 1)Study completedNCT00646139
What this trial is testing

KX2-391 in Treating Patients With Advanced Solid Tumors or Lymphoma That Did Not Respond to Treatment

Who this might be right for
LymphomaLymphoproliferative DisorderSmall Intestine Cancer+1 more
Roswell Park Cancer Institute 7
Not applicableStudy completedNCT06857500
What this trial is testing

Brentuximab Vedotin with Adriamycin, Vinblastine and Dacarbazine for Patients Aged 18-59 Years with Untreated Advanced-stage Classical Hodgkin Lymphoma: a Real-life Experience

Who this might be right for
Classic Hodgkin LymphomaAdvanced Hodgkin Lymphoma
Federico II University 200
Testing effectiveness (Phase 2)Ended earlyNCT00722865
What this trial is testing

Avastin (Bevacizumab) Plus Adriamycin, Bleomycin, Vinblastine and Dacarbazine (ABVD) for Advanced Stage Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
Massachusetts General Hospital 25
Large-scale testing (Phase 3)Study completedNCT01712490
What this trial is testing

A Frontline Therapy Trial in Participants With Advanced Classical Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
Takeda 1,334
Testing effectiveness (Phase 2)Study completedNCT01660607
What this trial is testing

Phase 1-2 MAHCT w/ TCell Depleted Graft w/ Simultaneous Infusion Conventional and Regulatory T Cell

Who this might be right for
Myeloid Leukemia, ChronicAcute Myelogenous LeukemiaMyelodysplastic Syndromes (MDS)+6 more
Stanford University 68
Early research (Phase 1)Study completedNCT00049296
What this trial is testing

Thalidomide and Docetaxel in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Case Comprehensive Cancer Center 26
Testing effectiveness (Phase 2)UnknownNCT05955105
What this trial is testing

ILB2109 and Toripalimab in Patients With Advanced Solid Malignancies

Who this might be right for
Head and Neck CancerCervical CancerEndometrial Cancer+7 more
Innolake Biopharm 200
Testing effectiveness (Phase 2)Study completedNCT03190174
What this trial is testing

Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain Cancers

Who this might be right for
Ewing SarcomaPEComaEpithelioid Sarcoma+11 more
Sarcoma Oncology Research Center, LLC 34
Early research (Phase 1)Study completedNCT02595866
What this trial is testing

Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer

Who this might be right for
AIDS-Related Non-Hodgkin LymphomaClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+16 more
National Cancer Institute (NCI) 58
Not applicableStudy completedNCT07171827
What this trial is testing

Anti-CD30 (Brentuximab Vedotin) With AVD Versus ABVD Chemotherapy Protocol Frontline Therapy in Patients With Advanced Classical Hodgkin Lymphoma

Who this might be right for
Anti-CD30BrentuximabDoxorubicin+4 more
Helwan University 60
Large-scale testing (Phase 3)Ended earlyNCT00005090
What this trial is testing

S9901 Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Men With Stage III or Stage IV Hodgkin's Disease

Who this might be right for
Lymphoma
SWOG Cancer Research Network 11
Testing effectiveness (Phase 2)UnknownNCT00795613
What this trial is testing

Positron Emission Tomography (PET)-Adapted Chemotherapy In Advanced Hodgkin Lymphoma (HL)

Who this might be right for
HODGKIN LYMPHOMA
Ospedale Santa Croce-Carle Cuneo 450
Large-scale testing (Phase 3)Study completedNCT03159897
What this trial is testing

FIL Study on ABVD DD-DI as Upfront Therapy in HL.

Who this might be right for
Hodgkin Lymphoma
Fondazione Italiana Linfomi - ETS 500
Large-scale testing (Phase 3)Active Not RecruitingNCT03907488
What this trial is testing

Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma

Who this might be right for
Ann Arbor Stage III Hodgkin LymphomaAnn Arbor Stage III Lymphocyte-Depleted Classic Hodgkin LymphomaAnn Arbor Stage III Mixed Cellularity Classic Hodgkin Lymphoma+7 more
National Cancer Institute (NCI)
Early research (Phase 1)UnknownNCT03374007
What this trial is testing

Phase I Clinical Trial in Chinese Patients of Advanced and (or) Recurrent Solid Tumor/Lymphoma

Who this might be right for
Advanced Solid TumorRecurrent Solid TumorLymphoma+1 more
Genor Biopharma Co., Ltd. 72
Testing effectiveness (Phase 2)Active Not RecruitingNCT04067037
What this trial is testing

Camrelizumab Combined With AVD in the First-line Treatment for Patients With Advanced Classical Hodgkin's Lymphoma

Who this might be right for
Classical Hodgkin Lymphoma
Henan Cancer Hospital 60
Testing effectiveness (Phase 2)Looking for participantsNCT07234487
What this trial is testing

Comparison of AVD + Low-Dose Nivolumab vs. PET-Adapted BEACOPP-like in Advanced cHL

Who this might be right for
Hodgkin Lymphoma
St. Petersburg State Pavlov Medical University 178
Testing effectiveness (Phase 2)Looking for participantsNCT02332668
What this trial is testing

Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)

Who this might be right for
MelanomaLymphomaSolid Tumor+2 more
Merck Sharp & Dohme LLC 370
Testing effectiveness (Phase 2)Looking for participantsNCT07209059
What this trial is testing

PET-Adapted First-Line Therapy With Nivolumab for Advanced Hodgkin Lymphoma

Who this might be right for
Hodgkin LymphomaHodgkin DiseaseAdvanced Hodgkin Lymphoma
National Research Center for Hematology, Russia 30
Testing effectiveness (Phase 2)Ended earlyNCT05714553
What this trial is testing

NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours

Who this might be right for
Advanced CancerAdvanced Solid TumorNeoplasm Malignant+14 more
NuCana plc 19
Next Page
994